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Abstract
Background: The risk of serious congenital anomaly for de novo balanced
translocations is estimated to be at least 6%. We identified two apparently inde-
pendent families with a balanced t(1;12)(q43;q21.1) as an outcome of a “System-
atic Survey of Balanced Chromosomal Rearrangements in Finns.” In the first
family, carriers (n = 6) manifest with learning problems in childhood, and later
with unexplained neurological symptoms (chronic headache, balance problems,
tremor, fatigue) and cerebral infarctions in their 50s. In the second family, two
carriers suffer from tetralogy of Fallot, one from transient ischemic attack and one
from migraine. The translocation cosegregates with these vascular phenotypes and
neurological symptoms.
Methods and Results: We narrowed down the breakpoint regions using mate
pair sequencing. We observed conserved haplotypes around the breakpoints,
pointing out that this translocation has arisen only once. The chromosome 1
breakpoint truncates a CHRM3 processed transcript, and is flanked by the 50 end
of CHRM3 and the 30 end of RYR2. TRHDE, KCNC2, and ATXN7L3B flank the
chromosome 12 breakpoint.
Conclusions: This study demonstrates a balanced t(1;12)(q43;q21.1) with con-
served haplotypes on the derived chromosomes. The translocation seems to result
in vascular phenotype, with or without neurological symptoms, in at least two
families. We suggest that the translocation influences the positional expression of
CHRM3, RYR2, TRHDE, KCNC2, and/or ATXN7L3B.
KEYWORD S
balanced translocation, conserved haplotypes, mate pair sequencing, position effect, vascular
phenotypes
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1 | INTRODUCTION
Reciprocal balanced translocations are prevalent chromoso-
mal aberrations with the incidence of c. 1:600 births. At
least 6% of balanced translocations cause diseases (Warbur-
ton, 1991). Reciprocal translocations are nonrandomly dis-
tributed in the human genome due to selective advantage
and more frequent potential of some DNA sequences to
mediate breakage and recombination. The involvement of
multiple mechanisms in the DNA breakage and repair pro-
cess have been proposed. These mechanisms include (1)
nonallelic homologous recombination (NAHR), (2) nonho-
mologous end joining (NHEJ), (3) microhomology-
mediated break-induced replication (MMBIR), and (4) fork
stalling and template switching (FoSTeS) (Gajecka et al.,
2008; Gu, Zhang, & Lupski, 2008). Breakpoint analysis of
disease-associated rearrangements can elucidate the etiol-
ogy and molecular mechanisms associated with disease
phenotypes.
Cerebral infarction, or stroke, is a major cause of mor-
bidity and death with a considerable economic burden to
the modern society. It is a late-onset, complex multifacto-
rial disease; however, it can be a manifestation of a number
of monogenic disorders that may boost the research toward
treatments. Epidemiological studies and animal models
strongly suggest genetic influences in the pathogenesis.
Recent association studies on stroke have implicated sev-
eral loci including HDAC9 (OMIM *606543), PITX2
(OMIM *601542), ZFHX3 (OMIM *104155), NINJ2
(OMIM *607297), 9q21, KRTDAP (OMIM *617212),
PLEKHA1 (OMIM *607772), IL15 (OMIM *600554),
NDFIP2 (OMIM *610041), SLC6A11 (OMIM *607952),
SLC6A9 (OMIM *601019), NAA25 (OMIM *612755), and
ALDH2 (OMIM +100650) (Kilarski et al., 2014; Traylor
et al., 2012).
Tetralogy of Fallot (TOF; OMIM 187500) is a rare (1/
2,000), complex congenital heart defect manifesting with
four classical structural defects: a ventricular septal defect,
pulmonary stenosis, right ventricular hypertrophy, and
overriding aorta. Symptoms include episodes of cyanosis as
some of the oxygen-poor blood fails to reach the lungs.
TOF is associated with chromosome 22q11 deletion syn-
drome and trisomy 21, and it can be caused by heterozy-
gous variants in JAG1 (OMIM +601920), NKX2-5 (OMIM
*600584), and GATA4 (OMIM *600576) (Benson et al.,
1999; Eldadah et al., 2001; Tomita-Mitchell, Maslen, Mor-
ris, Garg, & Goldmuntz, 2007). Variants in ZFPM2
(OMIM *603693), GDF1 (OMIM *602880), TBX1 (OMIM
*602054), and GATA6 (OMIM *601656) have been identi-
fied in sporadic TOF cases (Karkera et al., 2007; Maitra,
Koenig, Srivastava, & Garg, 2010; Pizzuti et al., 2003;
Rauch et al., 2010).
Translocations form through DNA double-strand break-
age (DSBs) followed by ligation repair processes. DNA
DSBs with open DNA ends can be aligned and joined
based on regional sequence homology through NAHR.
NAHR is mediated by large tracks of LCRs or shorter
homologous repetitive regions (Mefford & Eichler, 2009;
Rudd et al., 2009; Sharp et al., 2006). DNA DSBs can also
rejoin in the absence of sequence homology through NHEJ.
NHEJ is a distinctive repair mechanism for its imprecision
in leaving microalterations, “DNA scars,” which are seen
at the breakpoint junctions of nonrecurrent rearrangements
(Lieber, 2008; Pfeiffer, Goedecke, & Obe, 2000; Sargent,
Brenneman, & Wilson, 1997; Yu & Gabriel, 2004). Recur-
rent translocations with clustered breakpoints arise through
NAHR mediated by interchromosomal paralogous LCRs
(Ou et al., 2011). NAHR between interspersed LINE and
SINE/Alu elements can also result in translocations, which
is further supported by Alu elements present in the LCR
junctions (Bailey, Liu, & Eichler, 2003; Deininger, Moran,
Batzer, & Kazazian, 2003; Elliott, Richardson, & Jasin,
2005). Identical Alu elements seem to mediate translocation
formation through single-strand annealing (SSA) repair,
while diverged Alu elements seem to promote NHEJ repair
(Elliott et al., 2005).
The majority of translocations are assumed to be unique
(nonrecurrent), lacking significant breakpoint spanning
sequence homology. To date, only a few recurrent translo-
cations have been described in humans. The shared rear-
rangement-prone breakpoint intervals of recurrent
translocations provide cues to rearrangement formation.
Recurrent t(11;22)(Kurahashi et al., 2000) and t(8;22)
(Sheridan et al., 2010) are mediated by palindromic AT-
rich repeats. In t(8;22), the chromosome 8 palindromic AT-
rich repeat is flanked by two highly homologous Alu
repeats that are in an inverted orientation with respect to
one another. These Alu elements may also contribute to the
translocation formation. Recurrent t(4;8) (Giglio et al.,
2002), t(4;10)(van der Maarel et al., 2000), and t(4;11)( Ou
et al., 2011; South et al., 2008) are mediated by low-copy
repeats (LCRs). The origin of potentially recurrent translo-
cations can be determined by breakpoint mapping com-
bined with haplotyping. Haplotype analysis enables
differentiation between identical-by-descent (IBD) DNA
segments at breakpoints versus genuinely recurrent break-
points that have arisen more than once.
Balanced translocations affect the nuclear organization
of chromosomes. The extent to which the spatial organiza-
tion of the genome contributes to translocation formation
has been investigated, but is not yet fully understood
(Zhang et al., 2012). High-resolution chromosome confor-
mation capture (Hi-C) can reveal topologically associating
domains (TADs), which are chromatin compartments with
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physical interactions at conserved positions (Dixon et al.,
2012). Disruption of TAD boundaries by translocations
may be deleterious due to long-range position effect caused
by displacement of regulatory elements.
Chromosomal breakpoints have been used as signposts
for critical genes in human disease (Johnson et al., 2006;
Ray et al., 1985; Viskochil et al., 1990). The underlying
pathogenetic mechanisms may be versatile, such as dosage-
sensitive break (single functional copy is insufficient for nor-
mal gene function), gene fusion (chimeric gene), position
effect (dysregulation of gene expression through dislocation
and disruption of noncoding elements such as RNA genes or
conserved nongenic sequences; Dermitzakis, Reymond, &
Antonarakis, 2005; Mattick, 2005), or unmasking of reces-
sive variants (normal homologous chromosome becomes
unmasked). The consequence may be haploinsufficiency,
dominant-negative or gain-of-function effect of a fusion pro-
tein, elevated expression, or complete absence of protein pro-
duct when the other allele is imprinted or otherwise mutated.
In addition to an intact coding sequence, the spatially,
temporally, and quantitatively correct gene expression
requires regulatory control. In a variety of disease-related
cases, it is not the transcription unit but the altered regula-
tion of gene expression that is affected. Such cases are cat-
egorized as “position effect.” When translocation separates
the promoter or transcription unit from a regulatory ele-
ment, it may reduce or silence the transcription, whereas
removal of a silencer may lead to inappropriate activation
of the gene. A translocation may also juxtapose a gene
next to another regulatory element, or an euchromatic gene
next to a region of heterochromatin, again resulting in inap-
propriate expression (Festenstein et al., 1996; Milot et al.,
1996).
In this study, we utilized mate pair sequencing (MPS)
and haplotyping to characterize the exact chromosomal
breakpoints of a balanced t(1;12)(q43;q21.1) in two appar-
ently independent families. The families suffer from vascu-
lar phenotypes including cerebral infarction and TOF.
2 | MATERIALS AND METHODS
Informed consents approved by the Ministry of Social
Affairs and Health and Ethical Committees of the Joint
Authority for the Hospital District of Helsinki and Uusimaa
were obtained for further characterization of the families
and their chromosomal rearrangements.
2.1 | Systematic Survey of Balanced
Chromosomal Rearrangements in Finns
We have launched a national survey of balanced chromoso-
mal rearrangements (BCRs) in Finns by ascertaining all
known carriers (n = 3,016) from medical genetics depart-
ments and clinical genetics laboratories in Finland. Our
database contains medical records of all available carriers
including family members carrying the same rearrangement
IBD. From this resource, we have drawn families with
apparent correlating phenotype to the balanced transloca-
tion. In our gene-mapping pilot, we identified a potential
positional candidate gene for intracranial and aortic aneur-
ysm. The survey and database are described more broadly
in our prior publication (Luukkonen et al., 2012).
2.2 | The International Breakpoint Mapping
Consortium
In Denmark, the Wilhelm Johannsen Centre for Functional
Genome Research, coordinated by Professor Niels Tom-
merup, has organized the International Breakpoint Mapping
Consortium (IBMC) for the systematic mate pair mapping
of ~10,000 constitutional BCRs. Currently, 160 research
institutions have joined the consortium. The focus of the
consortium project is on both post- and prenatally diag-
nosed BCRs, on de novo and familial BCRs, and on BCRs
associated with both affected and unaffected individuals.
The aim is to enroll ~4,500 subjects who have previously
been diagnosed with constitutional apparently balanced
chromosomal translocations or inversions.
MPS, utilized by the IBMC project, has dramatically
simplified high-throughput mapping of BCRs. As BCRs
are heterogeneous, an optimal exploitation requires both
the concerted effort and large number of participating insti-
tutions. When achieved, the huge number of accessible
BCRs will become a unique resource for the identification
of human genotype–phenotype associations.
2.3 | Cytogenetic analysis
Standard cytogenetic analyses were performed to verify
earlier karyotyping. Blood samples were obtained from
individuals A1, A2, and B1. G-banding karyotype analysis
was performed from peripheral blood lymphocytes accord-
ing to standard protocols.
2.4 | Genome-wide mate pair sequencing
To identify the exact translocation breakpoints, we used
next-generation MPS method on genomic DNA extracted
from the blood lymphocytes of patients A1, A2, and B1.
For individuals A1 and A2, mate pair libraries were pre-
pared using 5500 SOLiDTM Mate-Paired Library Kit
(Thermo Scientific, Waltham, MA, USA) at DNA
Sequencing and Genomics Laboratory, Institute of Biotech-
nology, University of Helsinki. The DNA integrity was
evaluated by agarose gel electrophoresis, and concentration
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was quantified using Invitrogen QubitTM fluorometer
(Thermo Scientific). Genomic DNA (5 lg) was sheared
using the CovarisTM System (Covaris, Inc., Woburn, MA,
USA) to yield average 1.5 kb fragments. After circulariza-
tion, nick-translation, end-repair, and A-tailing Illumina
TruSeq adapters were ligated. Final mate pair libraries were
size selected to ~500 bp fragments and were subjected to
2 9 150 base paired end sequencing using Illumina
HiSeq2500 Rapid Run sequencing platform.
For individual B1, mate pair library was prepared at the
Wilhelm Johannsen Centre for Functional Genome
Research, Denmark. The integrity was evaluated by agarose
gel electrophoresis and concentrations measured by Nan-
odrop ND-1000 spectrometer (Thermo Scientific). Nextera
mate pair libraries were constructed using 1 lg of DNA
following the instruction for a gel-free preparation of 2 kb
effective insert size Mate Pair Library v2 (Nextera Mate
Pair Library Prep; Illumina, San Diego, CA, USA). Final
libraries were quantified using Pico Green (Quant-iT; Invit-
rogen). Four different indexed libraries were pooled
together with other samples and sequenced on a single lane
of the HiSeq2500 (Illumina) (2 9 100 bp).
2.5 | Data processing
2.5.1 | Patients A1 and A2
Raw sequence reads were quality checked using FastQC.
Reads were processed using Cutadapt against Illumina
TrueSeq adaptors and circularization adaptor. Sequence
bases with phred score quality <10 were trimmed, and
reads shorter than 20 bp were discarded. Processed read
sets were quality checked by FastQC, and then aligned to
the human reference genome (GRCh37/hg19/
GCA_000001405.1) using NovoAlign V2 software (Novo-
craft Technologies Sdn Bhd, Selangor, Malaysia) with
quality calibration and Mate Pair mode. Picard mark dupli-
cates was performed on the merged BAM file for each set.
Alignments generated by NovoAlign were analyzed with
Samtools genotyper (http://samtools.sourceforge.net) to call
for single-nucleotide variants and microshort indels. The
variants called were then annotated with SnpEff (http://
snpeff.sourceforge.net) and Ensembl Variant Effect Predic-
tor (VEP) (http://www.ensembl.org/info/docs/tools/vep).
For structural variant (SV) detection, BAM files were run
through Breakdancer (http://breakdancer.sourceforge.net)
and Pindel (Ye, Schulz, Long, Apweiler, & Ning, 2009),
and SVs were annotated using VEP. From the processed
uniquely mapping read pairs, we searched for those span-
ning the breakpoints. Read pairs aligning with unexpected
orientation or distances were defined as discordant. We
used the integrative genomics viewer (IGV) (Broad Insti-
tute, Cambridge, Massachusetts, USA) to visualize
discordant reads aligning to different chromosomes and
find the approximate region of the breakpoints.
2.5.2 | Patient B1
Raw sequence reads were first trimmed and then Cutadapt
was used to remove the adaptors. The remaining pairs pass-
ing Illumina Chastity filtering (>0.6) were mapped to the
human reference genome (GRCh37/hg19) using Burrows
Wheeler Aligner (BWA) (Li & Durbin, 2010). To annotate
the unique SVs, reads not aligning uniquely, were removed
and the ones with unexpected orientation or aligning to dif-
ferent chromosomes were extracted using SVDetect (http://
svdetect.sourceforge.net/)(Zeitouni et al., 2010) and Delly
(www.korbel.embl.de/software.html). The predicted SVs
were compared with multiple in-house mate pair datasets to
identify sample-specific SVs. By uploading the annotated
BED files into IGV (Broad Institute), we visualized the
SVs and found the approximate region of the breakpoints.
The depth of coverage of the aligned mate pair reads was
used to detect copy number changes.
In all patients, confirmatory screening across the translo-
cation junction fragments, suggested by MPS, was con-
ducted using Sanger sequencing. To identify interspersed
repetitive elements near the breakpoints, we referred to the
UCSC Genome Browser (GRCh37/hg19).
2.6 | Exclusion of relatedness
To exclude any unknown relatedness, individuals A1 and
B1, and additional 700 controls representative of the gen-
eral Finnish population, were genotyped at the Institute for
Molecular Medicine Finland (FIMM) Technology Centre
using the Illumina Human CoreExome-24_v1-1_A (Illu-
mina). Relatedness was determined using the IBD calcula-
tion and multidimensional scaling (MDS) on PLINK whole
genome association analysis toolset version 1.07 (Purcell,
2007).
2.7 | Haplotype analysis
We applied haplotype analysis to determine the origin of
t(1;12)(q43;q21.1) in our families. We genotyped one indi-
vidual per family using the Illumina Human CoreExome-
24_v1-1_A (Illumina) at the FIMM Technology Centre.
For the IBD shared segment detection, we used the Beagle
software packages v4.0 and v4.1 (Browning & Browning,
2013). We pruned the genotype data using PLINK v1.9
software to exclude SNPs with pairwise genotypic
r2 > 50% within sliding windows of 100 SNPs with a 25-
SNP increment between windows (Purcell, 2007). For the
replication haplotype analysis, we used FISHR2 IBD seg-
ment detection program (Bjelland, Lingala, Patel, Jones, &
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Keller, 2017). The used settings for this software allowed
no gaps in the shared segments. The suitability of the used
–emp-pie-threshold value 0.015 and –emp-ma-threshold
value 0.045 were tested with the parameter_finder tool
included in the FISHR2 package and were found to be
very conservative and ruling out the majority of false posi-
tives in this material. Prior to FISHR2 analysis, the SNP
data were phased using SHAPEIT (Delaneau, Marchini, &
Zagury, 2011).
3 | RESULTS
3.1 | Cytogenetic analysis
Standard karyotype analysis displayed a balanced transloca-
tion t(1;12)(q42.3;q15) for patients A1 and A2, and t(1;12)
(q42;q15) for patient B1 (Figure 1).
3.2 | Clinical summary
3.2.1 | Family A
The proband contacted us with concern that the balanced
translocation t(1;12) causes medical problems in their fam-
ily. The proband, all three children, and two of five grand-
children carry the translocation and have similar symptoms,
which no-one else manifests in their family. As a child,
they had specific learning problems. As a middle aged,
they suffer from a chronic headache, balance problems, tre-
mor, and fatigue. The oldest retired early, and the two old-
est, the proband and the eldest child, have had strokes at
the ages of 53–58. The youngest child has been hospital-
ized suspected of TIA at the age of 44. The oldest grand-
child has been examined because of hyperkinetic
disturbance of attention, and the youngest for special diffi-
culties in development and attention. Both grandchildren
have been rehabilitated and are progressing well to normal
school. In their extensive examinations, the neurologists,
the otorhinolaryngologists, the neuropediatricians, the psy-
chologists, the general practitioners, and the clinical geneti-
cists have often referred to the translocation as causal but
failed to set a specific diagnosis. There is no predisposing
alcohol, tobacco, cholesterol, coagulation factor, nor neuro-
logical, psychiatric, or otorhinolaryngological disease.
3.2.2 | Family B
The proband sought for doctor’s appointment because of
recurrent miscarriages. The proband had migraine, but was
otherwise healthy. The karyotype analyses revealed a bal-
anced translocation t(1;12) segregating in the family. Soon
the proband conceived for their second child. The fetus had
inherited the translocation and had TOF. The proband’s
parent had also TOF and carried the translocation. The
grandparents are not known to have had heart problems,
but the great grandparent died under 40 years of age and
delivered a dysmorphic child, who deceased neonatally.
The proband’s parent’s sibling is a carrier of the transloca-
tion and has suffered from TIA, hypertension, and two mis-
carriages with the spouse. Their second child has mitral
regurgitation and arrhythmia, but no karyotype analysis has
been performed and is not available for analysis. The pedi-
grees of the families are given in Figure 2.
3.3 | Breakpoint mapping
We refined the translocation breakpoints based on the MPS
findings to t(1;12)(q43;q21.1) for patients A1 and A2, and
to t(1;12)(q43;q21.1) for patient B1. We narrowed down
the breakpoint regions to 6 bp on chromosome 1, and
42 bp on chromosome 12, defined by the overlapping read
pairs (Figure 3a,b). Sanger sequencing mapped the exact
breakpoint positions to chr1:239,567,377–239,567,379 and
chr12:73,989,462–73,989,463 (Figure 4). The translocation
breakpoint positions and the surrounding genomic architec-
ture were identical at base pair level in all patients (Fig-
ure 5). Analysis of the flanking sequences revealed a
breakpoint intersecting SINE/AluY element on chromo-
some 1, and a SINE/AluSz element in the close vicinity of
the chromosome 12 breakpoint (71 bp upstream) (Fig-
ure 4b,e). Two simple repeats, (GA)n (size = 83 bp) and
(GAAA)n (size = 174 bp) map 63 bp upstream and
232 bp downstream from the chromosome 1 breakpoint,
respectively (Figure 4b). We detected no apparent regional
microhomology between the breakpoint junctions. We iden-
tified a breakpoint flanking microduplication and an inser-
tion: the chromosome 1 breakpoint contained a three base
pair duplication of “ACG” present in both derivative chro-
mosomes, and the chromosome 12 breakpoint a single base
pair insertion of “A” present on the derivative chromosomeFIGURE 1 Ideogram with the breakpoint regions indicated
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12 (Figure 5). Both breakpoints are intergenic. The chro-
mosome 1 breakpoint truncates a CHRM3 processed tran-
script, and is flanked by two protein-coding genes at 1q43:
the 50 end of a protein coding CHRM3 (OMIM *118494)
(225 kb upstream) and the 30 end of RYR2 (OMIM
*180902) (1.6 Mb downstream). TRHDE (OMIM
*606950) (930 kb upstream), KCNC2 (OMIM *176256)
(1.5 Mb downstream), and ATXN7L3B (OMIM *615579)
(942 kb downstream) are located closest to the chromo-
some 12 breakpoint (Figure 4a,d).
3.4 | Exclusion of relatedness
We excluded relatedness between the two families carrying
the identical balanced t(1;12)(q43;q21.1) by performing
IBD testing and MDS. The estimated PI_HAT value for
the patients A2 and B1 was 0.0006. See Figure 6 for the
MDS plot.
3
3
2
d. 62 y (pulmonary emphysema) 
mitral regurgitation
ж
ж
ж ж
3 2 
ж
= Tetralogy of Fallot 
and translocation 
= translocation 
= karyotype analysis
n
d. 67 y (Alzheimer's disease)
migraine
TIA
ж
A1ж3
A2ж
жж ж ж
ж
TIA susp. (44)
stroke (58)
strokes (53; 53) 
= stroke (no common 
predisposing factors) 
= unexplained neurologic 
symptoms 
(learning difficulty,
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tremor, fatigue)
= translocation verified
ж = karyotype 
analysis
FIGURE 2 The pedigrees of the
families. In the pedigree (a), carriers
(n = 6) manifest first with learning
problems in childhood and later with
neurological symptoms (chronic headache,
balance problems, tremor, fatigue), TIA,
and cerebral infarctions in their fifties
without identified predisposing factor. The
numbers A1 and A2 in the pedigree refer to
the patient numbers in the text, patient A1
had a stroke at the age of 58, and patient
A2 had two strokes at the age of 53. In the
pedigree (b), two carriers suffer from
tetralogy of Fallot, one from TIA and one
from migraine
3.5 | Haplotype analysis
The t(1;12)(q43;q21.1) in the two apparently indepen-
dent families was IBD with identical breakpoint inter-
vals and conserved haplotypes. Based on the Beagle
v4.1 analysis, the shared haplotype extends ~1.8 Mb
upstream and 1 Mb downstream from the chromosome
1 breakpoint (LOD score = 6.59; LOD score threshold
for IBD segment = 3.0). For chromosome 12, the hap-
lotype extends 1.4 Mb upstream and 2.5 Mb down-
stream from the breakpoint (LOD score = 9.12). The
breakpoint flanking shared segments of IBD are pre-
sented in Figure 7. Based on the FISHR2 replication
analysis, the shared haplotype extends ~6.7 Mb
upstream and 0.9 Mb downstream from the chromosome
1 breakpoint. And for chromosome 12, the haplotype
extends ~15.6 Mb upstream and ~2.5 Mb downstream
from the breakpoint.
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4 | DISCUSSION
The translocation breakpoints mapped outside the putative
protein-coding genes (i.e., transcription unit and promoter
region remain intact), pointing to malfunction caused by a
position effect. As the translocation t(1;12)(q43;q21.1) dis-
rupts the CHRM3 processed transcript at 1q43, we postu-
late that it may affect potassium channel mediation in the
brain through compromised CHRM3 function. Dysfunction
may be induced via truncation of the CHRM3 processed
transcript with a potential role in the regulation of protein
coding CHRM3 expression, or alternatively via position
effect triggered by disruption of a relevant regulatory
element.
The chromosome 1 breakpoint at 1q43 is flanked by two
genes: cholinenergic receptor muscarinic 3 (CHRM3,
225 kb upstream) and ryanodine receptor 2 (RYR2, 1.6 Mb
downstream). Chromosome band 1q42 has previously
emerged in a linkage study suggesting a susceptibility gene
for episodic ataxia type III (EA3) (Cader, Steckley, Dyment,
McLachlan, & Ebers, 2005). EA3 is a very rare form with
vestibular ataxia, vertigo, tinnitus, and myokymia (Steckley,
Ebers, Cader, & McLachlan, 2001) (Cader et al., 2005).
CHRM3 encodes a muscarinic acetylcholine receptor M3
distributed widely throughout the body, for example, in the
smooth muscles, the endocrine and exocrine glands, the
lungs, the pancreas, and the brain. This receptor belongs to
a larger family of G protein-coupled receptors whose
FIGURE 3 The discordant mate pair reads between chromosomes 1 and 12. (a) Dark gray indicates reads with mate end sequence on
chromosome 12 and (b) blue indicates reads with mate end sequence on chromosome 1. In (a) and (b), the two upper most panels display solely
the discordant reads for patients B1 and A2, whereas the bottom panel displays all aligned reads for patient A2
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functions include adenylate cyclase inhibition, phospho-
inositide degeneration, and modulation of potassium chan-
nels through the action of G proteins. Muscarinic M3
receptors are expressed in the hypothalamus and the dorsal
vagal complex of the brainstem, regions of the brain that
regulate insulin homeostasis. Their activation causes smooth
FIGURE 4 The chromosome breakpoints (connecting dashed line) adapted from the UCSC Genome Browser (http://genome.ucsc.edu) (a, b,
d, e) and the Sequencher 5.4.5 Software (c, f). An AluY element (=bright turquoise) is intersecting the chromosome 1 breakpoint (b), and an
AluSZ (=bright turquoise) element lies 71 bp downstream of the chromosome 12 breakpoint (e). The chromosome 1 breakpoint is flanked by the
30 end of CHRM3 (NG_032046.2, 225 kb). On the chromosome 12, TRHDE (NG_046971.1, 930 kb), KCNC2 (NC_000012.12, 1.5 Mb), and
ATXN7L3B (NC_000012.12, 942 kb) are adjacent to the breakpoint. The simple repeats, (GA)n (size = 83 bp) and (GAAA)n (size = 174 bp) on
the chromosome 1 are indicated in light blue (b)
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muscle contraction and secretion from glandular tissue.
Transmembrane potassium transport contributes fundamen-
tally to the regulation of the membrane potential and neu-
ronal signaling and prevents neuronal hyperexcitability,
which in turn is believed to trigger ataxia and seizures.
The ryanodine receptor 2 (RYR2) found in cardiac mus-
cle sarcoplasmic reticulum functions as a component of a
calcium channel that supplies calcium to cardiac muscle.
RYR2 has an essential role in embryonic cardiogenesis. Its
mutations have been associated with stress-induced poly-
morphic ventricular tachycardia and arrhythmogenic right
ventricular dysplasia. RYR2 is most abundantly expressed
in the brain, while all three isoforms are highly expressed
in the cerebellum, hippocampus, olfactory region, basal
Chr1 AGCACTTTGGGAGGCCAAGGTGGGCGAATCACGAGATCGAGACCATCCTGGCTAACACAGTGA
Der1 AGCACTTTGGGAGGCCAAGGTGGGCGAATCACGTTATATTCTTCACCAATTGCAAGTACATAGC
Der12 GATGCATTCCTATAAAGAATCATATTTTAATACGAGATCGAGACCATCCTGGCTAACACAGTGA
Chr12 GATGCATTCCTATAAAGAATCATATTTT ATATTATATTCTTCACCAATTGCAAGTACATAGCT
FIGURE 5 The translocation breakpoint junction fragment sequences. The reference sequences are labeled in blue and pink for the
chromosome 1 and the chromosome 12, respectively. A single base pair insertion “A” is bolded in pink in the der(12). An “ACG” duplication is
bolded in blue in the der(1) and the der(12). Chr, chromosome; Der, derivative chromosome
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FIGURE 6 The multidimensional scaling analysis (MDS) scatter plot of the patients A2 and B1 (yellow dots) and 30 randomly selected
controls (representative of the general Finnish population) (blue dots) excludes relatedness
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ganglia, and cerebral cortex. The cerebral expression of
RyRs is under tight regulation undergoing changes
throughout development from embryonic to adult. Altered
calcium signaling and RyR dysregulation have been impli-
cated in neurodegenerative disorders such as Parkinson’s
disease and Alzheimer’s disease (Abu-Omar, Das, Szeto, &
Feng, 2017).
TRHDE, KCNC2, and ATXN7L3B are genes located
closest to the chromosome 12 breakpoint. TRHDE encodes
a thyrotropin-releasing hormone (TRH) degrading enzyme
that specifically cleaves and inactivates the neuropeptide
TRH. TRH is thought to modulate and normalize the cen-
tral nervous system activity through its neuromodulatory
functions that affect neuronal excitability (Metcalf & Dett-
mar, 1981). TRH and some of its stable analogs improve
neurologic dysfunctions such as neuronal death occurring
after TIA (Shishido et al., 1999). TRH therapy is used in
several neurologic disorders, including spinocerebellar
ataxia (SCA) where the improvement of ataxic gait is one
of the important pharmacological responses (Sobue et al.,
1983; Urayama, Yamada, Kimura, Zhang, & Watanabe,
2002). TRHDE is mainly expressed in the brain, including
cerebellar hemisphere, frontal cortex, cerebellum, and cor-
tex (http://www.gtexportal.org/home/gene/TRHDE). Herein,
we propose that the chromosome 12 translocation break-
point flanked by the 30 end of TRHDE may cause inappro-
priate activation of TRHDE through a position effect,
subsequently, potentially leading to excess inactivation of
TRH in the cerebellum.
KCNC2 encodes a potassium voltage-gated channel sub-
family C member 2 (KV3.2), which belongs to the delayed
rectifier class of channel proteins and is an integral mem-
brane protein that mediates the voltage-dependent potas-
sium ion permeability of excitable membranes. ATXN7L3B
is a single exon putative ataxin-7-like 3B gene of unknown
function. In their recent report, Rajakulendran, Roberts,
Koltzenburg, Hanna, & Stewart (2013) described the clini-
cal and genetic findings in a family with a 670 kb deletion
of chromosome 12q21 and neurodevelopmental delay with
cerebellar ataxia. KCNC2 and ATXN7L3B, lying within the
deleted region, were suggested to have a potential role in
the complex neurodevelopmental and ataxic phenotype of
the family. Variants in KCNC3 (KV3.3), a member of the
same subfamily closely related to KCNC2, have previously
been associated with SCA13 (Herman-Bert et al., 2000;
Parolin Schnekenberg et al., 2015; Pyle et al., 2015;
Waters et al., 2005, 2006). Variants in another potassium
channel gene, KCNA1 (KV1.1), underlie EA1 (Browne
et al., 1994). Ataxin gene variants in ATXN1, ATXN2,
ATXN3, and ATXN7 cause SCA1, SCA2, SCA3, and
SCA7, respectively. ATXN7L3B is highly expressed in the
brain, particularly cerebellar hemisphere, frontal cortex,
cerebellum, and hypothalamus (http://gtexportal.org/
home/gene/ATXN7L3B). However, there are no data on
the ATXN73B function, thus the potential pathogenic role
would require identification of variants in further families
with similar phenotypes. KCNC2 is also mainly expressed
in the brain, particularly frontal cortex, anterior cingulate
cortex, cortex, hypothalamus, pituitary, and hippocampus
(http://www.gtexportal.org/home/gene/KCNC2).
We examined the genomic architecture of both break-
point regions. Analysis revealed two types of junction
spanning sequence changes likely originating from the
rearrangement formation, including a single base pair
insertion “A” in der(12), and a trinucleotide “ACG” dupli-
cation present in both der(1) and der(12). We detected no
apparent regional microhomology between the breakpoint
junctions. However, carriers exhibit a breakpoint spanning
AlyY element in the chromosome 1, and an AluSz ele-
ment mapping 71 bp upstream from the chromosome 12
breakpoint. The identified Alu elements, with a 68.7%
sequence similarity, may have mediated formation of the
translocation via illegitimate homologous unequal recom-
bination. The lack of higher level regional microhomol-
ogy, proximity of the diverged Alu elements, and
insertion of the “DNA scars” at sites of repair, implies
NHEJ as an optional mechanism of translocation forma-
tion (Jeggo, 1998; Pfeiffer et al., 2000; Sargent et al.,
1997).
Here, we have described two families, unrelated by IBS
calculation and MDS analysis, carrying a t(1;12)(q43;
q21.1). Interestingly, conserved haplotypes around the
breakpoints suggest that in even apparently independent
families similar translocations may arise only once (with
the exception of reported recurrent translocations). The
putative genes, lying some distance from the breakpoints,
have previously been associated with similar clinical mani-
festations. We suggest that the translocation influences the
positional expression of CHRM3, RYR2, TRHDE, KCNC2,
and/or ATXN7L3B. The underlying mechanism may be the
disruption of a regulatory element, resulting in induced or
reduced gene expression and causing the vascular pheno-
types and neurological manifestations. However, the
translocation may cause a position effect even further
upstream or downstream from the breakpoint.
Our goal is to scrutinize the genetic basis of clinical
phenotypes in carriers of apparently balanced transloca-
tions. Chromosomal rearrangements are valuable signposts
for genes and regulatory loci in human disease, thus they
serve as an important resource for discovery and annota-
tion. Analysis of MPS data allows precise breakpoint detec-
tion and further refinement of previously identified
balanced and unbalanced rearrangements, moreover, pin-
pointing a causal gene for some patients. Due to its longer
insert sizes, MPS facilitates mapping across repetitive
regions and large introns.
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In conclusion, we identified two apparently independent
families manifesting with vascular phenotypes and neuro-
logical symptoms, and a translocation, in which breakpoint
formation is likely to be Alu mediated. The translocation
appears to produce the vascular phenotypes with a certain
degree of similarity, yet unique features are present as well.
The complex neurological symptoms, including learning
problems, chronic headache, balance problems, tremor, and
fatigue may be manifestations of the underlying vascular
disease affecting the brain. The observed divergence in
symptoms may be explained by variation in phenotypic
penetrance and expressivity due to different combinations
of modifying alleles and/or environmental factors between
the families. Further characterization of the vascular pheno-
type and neurological symptoms, including stroke and
TOF, requires identification of additional families with dis-
ruption of the chromosomal regions reported in this study.
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